Quantifying Preferences for CAR‐T Compared to Standard of Care as a First‐Line Treatment Among Patients With Multiple Myeloma by Jessie Sutphin, Thomas W. LeBlanc, Ellen Janssen, Laura Hester, Matthew J. Wallace, F. Reed Johnson, Shelby D. Reed

Get full text

Elranatamab versus physician’s choice of treatment in patients with triple-class exposed/refractory multiple myeloma: an updated matching-adjusted indirect comparison by Isha Mol, Yannan Hu, Thomas W LeBlanc, Joseph C Cappelleri, Haitao Chu, Guido Nador, Didem Aydin, Isabel Perez Cruz, Patrick Hlavacek

362 Evaluating the educational quality of ChatGPT as a health information resource for patients with acute myeloid leukemia (AML) by Mihir Patel, Fadzai Chinyengetere, Sanghee Hong, Chenyu Lin, Michele Sainvil, Allison O. Taylor, Brenda Branchaud, Kris W. Herring, Thomas W. LeBlanc

Get full text

Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review. by Yaping Chang, Gordon H Guyatt, Trevor Teich, Jamie L Dawdy, Shaneela Shahid, Jessica K Altman, Richard M Stone, Mikkael A Sekeres, Sudipto Mukherjee, Thomas W LeBlanc, Gregory A Abel, Christopher S Hourigan, Mark R Litzow, Laura C Michaelis, Shabbir M H Alibhai, Pinkal Desai, Rena Buckstein, Janet MacEachern, Romina Brignardello-Petersen

Get full text

Real-world analysis of strategies to prevent thrombosis and bleeding in adults with ALL treated with asparaginase by Joseph F. Mort, David Brighton, Benjamin Mautner, Eric Pierce, Farid Ghamsari, Cecily Allen, Darren D’Souza, Imari Patel, Justin Lawson, Clayton Jackson, Karin Abernathy, Bradley Yelvington, Ryan Miller, Bhagirathbhai Dholaria, Heather Wolfe, Jordan Infield, Susan C. Locke, Rory M. Shallis, Vu H. Duong, Daniel R. Reed, Katherine Walsh, Thomas W. LeBlanc, Michael Keng, Bethany Horton, Firas El Chaer

Get full text